Determining how effectively a drug is being absorbed by the human body is a tricky business.
While age and weight can give doctors a good indication, a patients’ metabolism, the foods they eat and other drugs they might be taking can all have an effect on efficacy.
Looking to solve this problem, engineers from the University of California, Santa Barbara have developed an implantable device that provides real time feedback on how much medication is currently in a person’s bloodstream.
While still in the early stages of development, the researchers say the prototype device, called MEDIC (Microfluidic Electrochemical Detector for In vivo Concentrations), could revolutionise the way treatment is given and measured in the future.
Kevin Plaxco, a professor of biomolecular science and engineering, believes it could even be used to deliver drugs automatically, with dosages based on the feedback generated by the device.
An artificial pancreas, which monitors glucose levels in diabetics and uses this information to inject a controlled amount of insulin, is an example of one such system.
The MEDIC device consists of a microfluidic chamber lined with gold electrodes from which drug-recognising biomolecules – in this case artificial DNA strands called aptamers – extend.
When the target molecule comes in contact with an aptamer, the strand recognises it and wraps around the molecule, delivering electrons from its tip to the electrode at the aptamer’s base. The tiny jolt of current signals the presence of the molecule.
Because previous iterations of the device failed within half an hour – due to the components in whole blood clinging to the sensors – the researchers decided to introduce a second flow into the chamber.
This acted like a filter, separating the large blood components from the small drug molecules.
In tests, the researchers found they could easily and accurately measure the effectiveness of a particular drug in the bloodstream, even when a cocktail of drugs was administered.
The Latest on: Drug levels in the bloodstream
via Google News
The Latest on: Drug levels in the bloodstream
- Cholesterol-lowering drugs appear to boost cancer immunotherapieson November 12, 2020 at 7:57 am
An injectable drug used to reduce stubbornly high cholesterol levels appears in animal studies to also enhance the immune response of anti-cancer therapies known as immune checkpoint inhibitors, a ...
- Glioblastoma Nanomedicine Breaks through Blood-Brain Barrier in Miceon November 12, 2020 at 4:00 am
Researchers develop first intravenous medication that can cross the blood-brain barrier in mice and treat malignant brain tumors.
- Nanotech jumps blood-brain barrier to kill cancer in miceon November 11, 2020 at 2:00 pm
"It's still a bit of a miracle to us.... I've worked in this field for more than 10 years and have not seen anything like this." ...
- Type 2 diabetes: Drug duo may remain effective for 2 yearson November 11, 2020 at 9:45 am
Doctors also prescribe drugs to stabilize patients’ blood glucose levels. The first-line treatment is metformin, but in some patients, the drug’s efficacy can decline over time, necessitating ...
- Amgen, AstraZeneca say experimental asthma drug meets trial goalon November 10, 2020 at 6:38 pm
Drugmakers Amgen Inc and AstraZeneca Plc said on Tuesday a pivotal trial found that their experimental medication tezepelumab significantly reduced asthma attacks for people with severe forms of the ...
- Blood Balance Advanced Formula Reviews – Does It Manage Blood Sugar Levels For Real?on November 10, 2020 at 2:16 am
Ingredient ingredients are Licorice root, Berberine HCI, Cayenne Pepper, Cinnamon Bark, Bitter Melon, Guggul, Banaba Leaf, Yarro Flower, Juniper Berry, White Mulberry.Jacksonville, FL , Nov. 10, 2020 ...
- Immunotherapy drugs trigger inflammatory arthritis in subset of cancer patientson November 9, 2020 at 10:35 pm
Since doctors began treating cancer patients with immunotherapy drugs called checkpoint inhibitors nearly a decade ago, they have observed that a subset of these patients experience a side effect that ...
- Why These Drugs Have Caught the FDA's Eyeon November 9, 2020 at 12:01 pm
But making the list doesn't mean anyone taking these drugs should toss them out. “The FDA uses this information, reports from other databases, and published research to determine if further action is ...
- Rare disease drug maker Ultragenyx plans to hire 100-150 at new gene therapy facility near Bostonon November 9, 2020 at 11:18 am
Rare disease drug developer Ultragenyx Pharmaceutical Inc. will hire as many as 150 people at a 100,000-square-foot gene therapy manufacturing facility near Boston that it expects to open in 2023. The ...
- Centhaquine drug improves outcomes, reduces death rate in patients with severe blood or fluid losson November 9, 2020 at 4:17 am
Centhaquine, a new medication to treat patients who have severe blood or fluid loss, significantly improved outcomes and reduced death rate when added to standard of care, compared to standard care ...
via Bing News